PER 0.00% 10.5¢ percheron therapeutics limited

Ann: ATL1103 Acromegaly Phase II Trial Results, page-92

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,414 Posts.
    lightbulb Created with Sketch. 1439
    I remember 2.5 years ago people were saying that Atl1103 for Acromegaly was never giving to be a Coy maker..market under $40 mill...however with the consolidation and better than expected results and going for a $200 mill market for Acromegaly these results in the next few days will be just that... A Coy maker.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.